Related references
Note: Only part of the references are listed.The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation
Anna U. Odland et al.
NEUROPHARMACOLOGY (2021)
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
Mario de la Fuente Revenga et al.
CELL REPORTS (2021)
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer M. Mitchell et al.
NATURE MEDICINE (2021)
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Psychedelics and Psychedelic-Assisted Psychotherapy
Collin M. Reiff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Effects of ghrelin receptor activation on forebrain dopamine release, conditioned fear and fear extinction in C57BL/6J mice
Anouk Pierre et al.
JOURNAL OF NEUROCHEMISTRY (2020)
The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
Simon B. Goldberg et al.
PSYCHIATRY RESEARCH (2020)
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
Functional and molecular heterogeneity of D2R neurons along dorsal ventral axis in the striatum
Emma Puighermanal et al.
NATURE COMMUNICATIONS (2020)
Stimulation of 5-HT receptors in anterodorsal BNST guides fear to predictable and unpredictable threat
Margarita Hessel et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Neural circuits for a top-down control of fear and extinction
Roger Marek et al.
PSYCHOPHARMACOLOGY (2019)
3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats
Holly S. Hake et al.
PHYSIOLOGY & BEHAVIOR (2019)
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
Allison A. Feduccia et al.
FRONTIERS IN PSYCHIATRY (2019)
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Silvia Muttoni et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4
C. Zussy et al.
MOLECULAR PSYCHIATRY (2018)
6 Hz corneal kindling in mice triggers neurobehavioral comorbidities accompanied by relevant changes in c-Fos immunoreactivity throughout the brain
Giulia Albertini et al.
EPILEPSIA (2018)
Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis
Andrea Cipriani et al.
PSYCHOLOGICAL MEDICINE (2018)
MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor
K. P. C. Kuypers et al.
PSYCHOPHARMACOLOGY (2018)
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice
Daniel W. Curry et al.
NEUROPHARMACOLOGY (2018)
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Allison A. Feduccia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial
Michael C. Mithoefer et al.
LANCET PSYCHIATRY (2018)
3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner
Elizabeth G. Pitts et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Post-Traumatic Stress Disorder
Arieh Shalev et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)
Matthew B. Young et al.
PSYCHOPHARMACOLOGY (2017)
Psychedelic Drugs in Biomedicine
Evan J. Kyzar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS
Daniel J. Lee et al.
DEPRESSION AND ANXIETY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
Rainer Kraehenmann et al.
NEUROIMAGE-CLINICAL (2016)
Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain
David A. Martin et al.
EBIOMEDICINE (2016)
Pharmacological profile of novel psychoactive benzofurans
Anna Rickli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis
Mathew Hoskins et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Psychotherapy for Military-Related PTSD A Review of Randomized Clinical Trials
Maria M. Steenkamp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Increased Serotonin Transporter Expression Reduces Fear and Recruitment of Parvalbumin Interneurons of the Amygdala
Marco Bocchio et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
N. Singewald et al.
PHARMACOLOGY & THERAPEUTICS (2015)
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
M. B. Young et al.
TRANSLATIONAL PSYCHIATRY (2015)
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
5-HT2C receptor involvement in the control of persistence in the Reinforced Spatial Alternation animal model of obsessive-compulsive disorder
Vassiliki-Maria Papakosta et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model
Chao-Chuan Wang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice
Gongliang Zhang et al.
NEUROPHARMACOLOGY (2013)
Cognitive dysfunction, elevated anxiety, and reduced cocaine response in circadian clock-deficient cryptochrome knockout mice
Dimitri De Bundel et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2013)
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Briony J. Catlow et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
Fear Extinction as a Model for Translational Neuroscience: Ten Years of Progress
Mohammed R. Milad et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 63 (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT2 and 5-HT1 Receptors
Janelle H. P. van Wel et al.
PLOS ONE (2012)
Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters
Y. Hagino et al.
CURRENT NEUROPHARMACOLOGY (2011)
Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour
Maria Juliana Orejarena et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Loss of System xc- Does Not Induce Oxidative Stress But Decreases Extracellular Glutamate in Hippocampus and Influences Spatial Working Memory and Limbic Seizure Susceptibility
Dimitri De Bundel et al.
JOURNAL OF NEUROSCIENCE (2011)
Effects of co-administration of bupropion and nicotine ord-amphetamine on the elevated plus maze test in mice
Grazyna Biala et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen
Clinton E. Canal et al.
PSYCHOPHARMACOLOGY (2010)
Brain structures implicated in the four-plate test in naive and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI
Benoit Petit-Demouliere et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Stimulation of 5-HT1A or 5-HT2A receptors in the ventrolateral periaqueductal gray causes anxiolytic-, but not panicolytic-like effect in rats
Vanessa de Paula Soares et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Stress Impairs 5-HT2A Receptor-Mediated Serotonergic Facilitation of GABA Release in Juvenile Rat Basolateral Amygdala
Xiaolong Jiang et al.
NEUROPSYCHOPHARMACOLOGY (2009)
5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice
Adam L. Halberstadt et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Alteration of Synaptic Transmission in the Hippocampal-mPFC Pathway During Extinction Trials of Context-Dependent Fear Memory in Juvenile Rat Stress Models
Hiroyo Koseki et al.
SYNAPSE (2009)
Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro
Stephane Doly et al.
JOURNAL OF NEUROSCIENCE (2008)
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor
Christopher D. Verrico et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Hypomobility after DOI administration can be reversed by subthalamic nucleus deep brain stimulation
Rob Hameleers et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice
Jose Manuel Trigo et al.
BIOLOGICAL PSYCHIATRY (2007)
Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice
N Ripoll et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine
DV Herin et al.
PSYCHOPHARMACOLOGY (2005)
A multidimensional meta-analysis of psychotherapy for PTSD
R Bradley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Intra-prefrontal S-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats
CA Winstanley et al.
PSYCHOPHARMACOLOGY (2003)
GABA-A and 5-HTIA receptor agonists block expression of fear-potentiated startle in mice
VB Risbrough et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1A receptors
Z Sarnyai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) are attenuated by the serotonin uptake inhibitor citalopram
ME Liechti et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
